Renovacare Inc (RCAR) financial statements (2021 and earlier)

Company profile

Business Address 4 BECKER FARM ROAD
ROSELAND, NJ 07068
State of Incorp. NV
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7,4138,67110,25811,38212,18513,37414,273
Cash and cash equivalents7,4138,67110,25811,38212,18513,37414,273
Prepaid expense   319103100193
Other current assets566274404    
Total current assets:7,9798,94510,66211,70112,28813,47414,466
Noncurrent Assets
Operating lease, right-of-use asset7987     
Property, plant and equipment3941  (1)00
Intangible assets, net (including goodwill) 153153153   
Intangible assets, net (excluding goodwill) 153153153   
Prepaid expense 159     
Deposits noncurrent assets 888   
Other noncurrent assets138      
Other undisclosed noncurrent assets161   154153153
Total noncurrent assets:417448161161153153153
TOTAL ASSETS:8,3969,39310,82311,86212,44113,62714,619
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,237585667294169413178
Accounts payable1,237  294169  
Other undisclosed accounts payable and accrued liabilities 585667  413178
Debt 44     
Due to related parties 1321311171126912
Other undisclosed current liabilities51     167
Total current liabilities:1,289762797411281483358
Noncurrent Liabilities
Long-term debt and lease obligation2942     
Operating lease, liability2942     
Other undisclosed noncurrent liabilities(29)      
Total noncurrent liabilities: 42     
Total liabilities:1,317804797411281483358
Stockholders' equity
Stockholders' equity attributable to parent7,0798,58910,02611,45112,16013,14514,261
Common stock1111111
Additional paid in capital36,84635,81234,43132,84532,37932,18832,188
Accumulated deficit(29,768)(27,224)(24,406)(21,395)(20,220)(19,045)(17,929)
Total stockholders' equity:7,0798,58910,02611,45112,16013,14514,261
TOTAL LIABILITIES AND EQUITY:8,3969,39310,82311,86212,44113,62714,619

Income statement (P&L) ($ in thousands)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Operating expenses(2,561)(2,843)(3,044)(1,228)(1,242)(1,201)(644)
Operating loss:(2,561)(2,843)(3,044)(1,228)(1,242)(1,201)(644)
Nonoperating income17253354678596
Net loss available to common stockholders, diluted:(2,544)(2,818)(3,012)(1,175)(1,175)(1,116)(548)

Comprehensive Income ($ in thousands)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Net loss:(2,544)(2,818)(3,012)(1,175)(1,175)(1,116)(548)
Comprehensive loss, net of tax, attributable to parent:(2,544)(2,818)(3,012)(1,175)(1,175)(1,116)(548)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: